BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

677 related articles for article (PubMed ID: 19580856)

  • 21. Ionotropic cross-linked chitosan microspheres for controlled release of ampicillin.
    Anal AK; Stevens WF; Remuñán-López C
    Int J Pharm; 2006 Apr; 312(1-2):166-73. PubMed ID: 16497452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of the type of release medium on drug release from PLGA-based microparticles: experiment and theory.
    Faisant N; Akiki J; Siepmann F; Benoit JP; Siepmann J
    Int J Pharm; 2006 May; 314(2):189-97. PubMed ID: 16510257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein micro and nanoencapsulation within glycol-chitosan/Ca²+/alginate matrix by spray drying.
    Erdinc B; Neufeld RJ
    Drug Dev Ind Pharm; 2011 Jun; 37(6):619-27. PubMed ID: 21449696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sustained release of antineoplastic drugs from chitosan-reinforced alginate microparticle drug delivery systems.
    Yu CY; Zhang XC; Zhou FZ; Zhang XZ; Cheng SX; Zhuo RX
    Int J Pharm; 2008 Jun; 357(1-2):15-21. PubMed ID: 18313867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of chitosan coating on the swelling and controlled release of a poorly water-soluble drug from an amphiphilic and pH-sensitive hydrogel.
    Colinet I; Dulong V; Mocanu G; Picton L; Le Cerf D
    Int J Biol Macromol; 2010 Aug; 47(2):120-5. PubMed ID: 20471413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controlled release study of 5-fluorouracil-loaded chitosan/polyethylene glycol microparticles.
    Lin CC; Fu CH
    Drug Deliv; 2009 Jul; 16(5):274-9. PubMed ID: 19538009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of furosemide-loaded alginate microspheres prepared by ionotropic external gelation technique.
    Das MK; Senapati PC
    Acta Pol Pharm; 2007; 64(3):253-62. PubMed ID: 17695149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein release kinetics for core-shell hybrid nanoparticles based on the layer-by-layer assembly of alginate and chitosan on liposomes.
    Haidar ZS; Hamdy RC; Tabrizian M
    Biomaterials; 2008 Mar; 29(9):1207-15. PubMed ID: 18076987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chitosomes as drug delivery systems for C-phycocyanin: preparation and characterization.
    Manconi M; Mura S; Manca ML; Fadda AM; Dolz M; Hernandez MJ; Casanovas A; Díez-Sales O
    Int J Pharm; 2010 Jun; 392(1-2):92-100. PubMed ID: 20338230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and in vitro evaluation of alginate gel-encapsulated, chitosan-coated ceramic nanocores for oral delivery of enzyme.
    Rawat M; Singh D; Saraf S; Saraf S
    Drug Dev Ind Pharm; 2008 Feb; 34(2):181-8. PubMed ID: 18302037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fabrication of microparticle protein delivery systems based on calcium alginate.
    Yu CY; Jia LH; Cheng SX; Zhang XZ; Zhuo RX
    J Microencapsul; 2010; 27(2):171-7. PubMed ID: 19538029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and release characteristics of polymer-coated and blended alginate microspheres.
    Lee DW; Hwang SJ; Park JB; Park HJ
    J Microencapsul; 2003; 20(2):179-92. PubMed ID: 12554373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alginate/chitosan microparticles for tamoxifen delivery to the lymphatic system.
    Coppi G; Iannuccelli V
    Int J Pharm; 2009 Feb; 367(1-2):127-32. PubMed ID: 18940240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Layer-by-layer assembly of poly(L-glutamic acid)/chitosan microcapsules for high loading and sustained release of 5-fluorouracil.
    Yan S; Zhu J; Wang Z; Yin J; Zheng Y; Chen X
    Eur J Pharm Biopharm; 2011 Aug; 78(3):336-45. PubMed ID: 21195174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preliminary evaluation of molecular imprinting of 5-fluorouracil within hydrogels for use as drug delivery systems.
    Singh B; Chauhan N
    Acta Biomater; 2008 Sep; 4(5):1244-54. PubMed ID: 18448400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel preparation techniques for alginate-poloxamer microparticles controlling protein release on mucosal surfaces.
    Moebus K; Siepmann J; Bodmeier R
    Eur J Pharm Sci; 2012 Feb; 45(3):358-66. PubMed ID: 22178531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Wheat germ agglutinin anchored chitosan nanoparticles and its conjugation with N-acetylglucosamine].
    Li H; Bi J; Xu XM; Li FQ
    Yao Xue Xue Bao; 2012 Jan; 47(1):131-4. PubMed ID: 22493818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.
    Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New amphiphilic and pH-sensitive hydrogel for controlled release of a model poorly water-soluble drug.
    Colinet I; Dulong V; Mocanu G; Picton L; Le Cerf D
    Eur J Pharm Biopharm; 2009 Nov; 73(3):345-50. PubMed ID: 19631739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microspheres of alginate-chitosan containing isoniazid.
    Lucinda-Silva RM; Evangelista RC
    J Microencapsul; 2003; 20(2):145-52. PubMed ID: 12554370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.